Council for europe portal
Language : en Search
Choose language

Pharmaceutical Practices and Pharmaceutical Care

"The safe and appropriate use of medicines is just as important as product quality"

 

"In a fast moving world full of new technologies introduced to prepare or to deliver medicines to patients we collectively have to ensure the optimal use of medicines for improving patients’ quality of life. Public authorities and the manufacturing and distribution sectors devote a lot of their resources to the quality, safety and efficacy of medicines. However, the safe and appropriate use of medicines is just as important as product quality to ensure a patient obtains the best possible outcome from their medicine."  Dr Henk Scheepers, Chair of the CD-P-PH/PC

 

Work programme: setting quality and safety standards in pharmaceutical practices and pharmaceutical care

The Committee of Experts on quality and safety standards in pharmaceutical practices and pharmaceutical care (CD-P-PH/PC) was entrusted with improving pharmaceutical care and practices in community and hospital pharmacy settings through specific programmes and policies. It:

 

Achievements

  • Automated Dose Dispensing (ADD): Guidelines on best practice for the ADD process and care and safety of patients.

The ADD guidelines have been developed by a working group of experts from industry, academia, pharmacy and government from across the region of the Council of Europe. These guidelines harmonise the standards and approaches to automated dose dispensing across Europe and are intended to be used by pharmacies and manufacturers involved in automated dose dispensing, as well as by national authorities in countries where this service is provided. They include standards regarding the ADD sites and operations, as well as patient care activities associated with the ADD process.

  • EDQM Pharmaceutical Care Quality Indicators Project.

Pharmaceutical care is understood as a quality concept and working method for the responsible provision of medicine therapy for definite outcomes in the interest of patients’ quality of life (Hepler and Strand’s definition - 1990). The main goal of the EDQM Pharmaceutical Care Quality Indicators Project was to develop, test and validate 4 sets of quality indicators. For each indicator set, pilot studies were carried out in different countries in Europe under real-life conditions, and in different healthcare settings. A total of 19 collaborators from 12 countries in Europe were involved in the last phase of the project. In conclusion the project drew up and validated 4 basic sets of quality indicators covering 4 key areas of the pharmaceutical care process. These indicators can be used by health authorities and healthcare professionals to evaluate pharmaceutical care practices and policies, and to promote the efficient and safe use of medicines, leading to the best possible medication outcome for the patient.

 

Resolutions

  • Reconstitution of medicinal products for parenteral use

Resolution CM/Res(2016)2 on good reconstitution practices in health care establishments for medicinal products for parenteral use (Adopted by the Committee of Ministers on 1 June 2016 at the 1258th meeting of the Ministers’ Deputies).

  • Pharmacy preparations

Resolution CM/Res(2016)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 1 June 2016 at the 1258th meeting of the Ministers’ Deputies)

  • Internet pharmacies

Resolution ResAP(2007)2 on Good Practices for Distributing Medicines via Mail Order (Adopted by the Committee of Ministers on 5 September 2007 at the 1003rd meeting of the Ministers’ Deputies) (currently under revision)

 

twitter facebook googleplus pinterest linkedin email